Finanzen Apollo Hospitals Enterprise Limited
Aktien
A1C4YK
INE437A01024
APOLLOHOSP
Gesundheitspflege Einrichtungen
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
7’008.05 INR | -0.33% | +2.15% | +22.86% |
Voraussichtliche Gewinn- und Verlustrechnung: Apollo Hospitals Enterprise Limited
Steuerjahr: März | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Umsatz 1 | 112’468 | 105’600 | 146’626 | 166’124 | 190’592 | 221’381 | 259’721 | 309’694 |
Veränderung | - | -6.11% | 38.85% | 13.3% | 14.73% | 16.15% | 17.32% | 19.24% |
EBITDA 1 | 15’873 | 11’374 | 21’851 | 20’065 | 24’106 | 31’114 | 38’645 | 47’219 |
Veränderung | - | -28.34% | 92.11% | -8.18% | 20.14% | 29.07% | 24.2% | 22.19% |
Betriebsergebnis (EBIT) 1 | 9’676 | 5’643 | 15’844 | 13’912 | 17’236 | 23’828 | 30’792 | 38’624 |
Veränderung | - | -41.68% | 180.79% | -12.19% | 23.89% | 38.24% | 29.23% | 25.44% |
Gezahlte Zinsen 1 | -5’328 | -4’492 | -3’786 | -3’808 | -4’494 | -4’295 | -3’838 | -3’220 |
Gewinn vor Steuern (EBT) 1 | 6’601 | 2’215 | 15’854 | 11’008 | 13’805 | 20’936 | 28’350 | 37’694 |
Veränderung | - | -66.45% | 615.84% | -30.57% | 25.41% | 51.66% | 35.41% | 32.96% |
Nettoergebnis 1 | 4’549 | 1’504 | 10’556 | 8’191 | 8’986 | 14’808 | 20’179 | 26’620 |
Veränderung | - | -66.95% | 602.06% | -22.41% | 9.71% | 64.79% | 36.27% | 31.92% |
Datum der Veröffentlichung | 25.06.20 | 23.06.21 | 25.05.22 | 30.05.23 | 30.05.24 | - | - | - |
Vorläufige Bilanz: Apollo Hospitals Enterprise Limited
Steuerjahr: März | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Nettoverschuldung 1 | 27’379 | 25’325 | 10’985 | 16’423 | 15’441 | 21’694 | 10’766 | -6’869 |
Veränderung | - | -7.5% | -56.62% | 49.5% | -5.98% | 40.5% | -50.37% | -163.8% |
Datum der Veröffentlichung | 25.06.20 | 23.06.21 | 25.05.22 | 30.05.23 | 30.05.24 | - | - | - |
Prognostizierter Cashflow: Apollo Hospitals Enterprise Limited
Steuerjahr: März | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX Investitionsaufwand 1 | 5’119 | 2’955 | 6’572 | 11’285 | 11’368 | 11’444 | 12’199 | 12’151 |
Veränderung | - | -42.28% | 122.4% | 71.72% | 0.73% | 0.67% | 6.6% | -0.39% |
Free Cashflow (FCF) 1 | 7’780 | 9’780 | 9’585 | 2’485 | 7’834 | 11’073 | 16’825 | 24’557 |
Veränderung | - | 25.71% | -2% | -74.07% | 215.21% | 41.34% | 51.95% | 45.95% |
Datum der Veröffentlichung | 25.06.20 | 23.06.21 | 25.05.22 | 30.05.23 | 30.05.24 | - | - | - |
Voraussichtliche Finanzkennzahlen: Apollo Hospitals Enterprise Limited
Steuerjahr: März | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Rentabilität | ||||||||
EBITDA-Marge (%) | 14.11% | 10.77% | 14.9% | 12.08% | 12.65% | 14.05% | 14.88% | 15.25% |
EBIT-Marge (%) | 8.6% | 5.34% | 10.81% | 8.37% | 9.04% | 10.76% | 11.86% | 12.47% |
EBT-Marge (%) | 5.87% | 2.1% | 10.81% | 6.63% | 7.24% | 9.46% | 10.92% | 12.17% |
Nettogewinn (%) | 4.05% | 1.42% | 7.2% | 4.93% | 4.71% | 6.69% | 7.77% | 8.6% |
FCF-Marge N (%) | 6.92% | 9.26% | 6.54% | 1.5% | 4.11% | 5% | 6.48% | 7.93% |
FCF / Nettogewinn (%) | 171.01% | 650.43% | 90.8% | 30.34% | 87.18% | 74.78% | 83.38% | 92.25% |
Rentabilität | ||||||||
ROA | 4.43% | 1.32% | 8.57% | 5.91% | 5.76% | 8.94% | 10.73% | 12.37% |
ROE | 13.64% | 3.79% | 20.6% | 13.86% | 13.68% | 19.04% | 21.58% | 23.2% |
Finanzielle Gesundheit | ||||||||
Verschuldungsgrad (Verbindlichkeiten/EBITDA) | 1.72x | 2.23x | 0.5x | 0.82x | 0.64x | 0.7x | 0.28x | - |
Verschuldung / Free Cashflow | 3.52x | 2.59x | 1.15x | 6.61x | 1.97x | 1.96x | 0.64x | - |
Kapitalintensität | ||||||||
CAPEX / Umsatz (%) | 4.55% | 2.8% | 4.48% | 6.79% | 5.96% | 5.17% | 4.7% | 3.92% |
CAPEX / EBITDA (%) | 32.25% | 25.98% | 30.07% | 56.24% | 47.16% | 36.78% | 31.57% | 25.73% |
CAPEX / FCF (%) | 65.8% | 30.21% | 68.56% | 454.08% | 145.11% | 103.35% | 72.51% | 49.48% |
Elemente pro Aktie | ||||||||
Cashflow pro Aktie 1 | 92.72 | 90.96 | 112.4 | 95.78 | 133.6 | 158.5 | 193.5 | 235.7 |
Veränderung | - | -1.89% | 23.53% | -14.76% | 39.44% | 18.67% | 22.1% | 21.82% |
Dividende pro Aktie 1 | 6 | 3 | 11.75 | 15 | 16 | 17.65 | 23.3 | 30.73 |
Veränderung | - | -50% | 291.67% | 27.66% | 6.67% | 10.34% | 31.98% | 31.89% |
Buchwert je Aktie 1 | 240 | 320.1 | 392.6 | 431 | 482.3 | 565.4 | 690.9 | 847.8 |
Veränderung | - | 33.34% | 22.67% | 9.78% | 11.9% | 17.23% | 22.19% | 22.71% |
Gewinn pro Aktie 1 | 32.7 | 10.74 | 73.42 | 56.97 | 62.5 | 102.4 | 139.7 | 185.1 |
Veränderung | - | -67.16% | 583.61% | -22.41% | 9.71% | 63.87% | 36.38% | 32.51% |
Anz. der Aktien (in Tausend) | 139’125 | 143’785 | 143’785 | 143’785 | 143’785 | 143’785 | 143’785 | 143’785 |
Datum der Veröffentlichung | 25.06.20 | 23.06.21 | 25.05.22 | 30.05.23 | 30.05.24 | - | - | - |
2025 * | 2026 * | |
---|---|---|
KGV | 68.4x | 50.2x |
KBV | 12.4x | 10.1x |
EV / Sales | 4.65x | 3.92x |
Rendite | 0.25% | 0.33% |
Gewinn pro Aktie & Dividende
Historische Entwicklung KGV
Entwicklung der Dividendenrendite
- Börse
- Aktien
- A1C4YK Aktie
- Finanzen Apollo Hospitals Enterprise Limited
MarketScreener is also available in this country: United States.
Switch edition